124 Results | Everything | Search

New Products

View New Products (1)

Product TypeClear Filters

Analytical Chemistry (11)

Biochemicals (124)

Antibiotics (1)

Antifungals (1)

Antivirals (6)

Antioxidants (2)

Kinase Inhibitors (124)

Abl Family & Bcr-Abl (7)

Aurora (4)

CaMKs (4)

CDKs (1)

EGFR/ErbB/HER Family (13)

ERK (1)

FAK Family (1)

FGFR Family (39)

HGFR Family (10)

IGF-1R/InsR Family (4)

IKKs (1)

IRAKs (1)

JAK Family (1)

MAP3Ks (2)

MEK (1)

mTOR (1)

Neurotrophin Receptor/Trk Family (3)

p38 MAPK (1)

PDGFR Family (78)

PDPK1/PDK1 (1)

PI3K (1)

PKA (2)

PKB/Akt (2)

PKC (1)

PKD & PKG (1)

RAF (10)

RET (13)

RIPKs (1)

SRC Family (14)

TAM Family (4)

Tec Family (2)

Tie Family (19)

VEGFR Family (124)

Other Non-Receptor Tyrosine Kinases (1)

Other Receptor Tyrosine Kinases (5)

Other Serine/Threonine Kinases (1)

Peptides (1)

Xenobiotic Metabolites (4)

Lipids (1)

Natural Products (2)

Small Molecule Modulators (123)

Research AreaClear Filters

Cancer (108)

Cardiovascular System (11)

Cell Biology (42)

Epigenetics, Transcription, & Translation (2)

Immunology & Inflammation (22)

Infectious Disease (7)

Neuroscience (4)

Oxidative Stress & Reactive Species (4)

Xenobiotic Metabolism (4)

ApplicationClear Filters

Mass Spectrometry (11)

Displaying 1 - 25 of 124 Results

SU 5416

A tyrosine kinase inhibitor

CAS No. 204005-46-9

Item No. 13342

Formulation: A crystalline solid

Purity: ≥98%

NSC 696819
Semaxinib
Sugen 5416
VEGFR 2 Kinase Inhibitor

10 mg

$142

Add

25 mg

$337

Add

50 mg

$603

Add

100 mg

$852

Add

BIBF 1120

A VEGFR, FGFR, and PDGFR inhibitor

CAS No. 656247-17-5

Item No. 11022

Formulation: A crystalline solid

Purity: ≥95%

Nintedanib

10 mg

$39

Add

50 mg

$106

Add

100 mg

$136

Add

250 mg

$290

Add

DMXAA

A STING activator and tumor vascular disrupting agent

CAS No. 117570-53-3

Item No. 14617

Formulation: A crystalline solid

Purity: ≥98%

ASA 404
5,6-Dimethylxanthenone-4-acetic Acid
NSC 640488
Vadimezan

1 mg

$39

Add

5 mg

$87

Add

10 mg

$136

Add

25 mg

$290

Add

Sorafenib

A multi-kinase inhibitor

CAS No. 284461-73-0

Item No. 10009644

Formulation: A crystalline solid

Purity: ≥98%

BAY 43-9006

5 mg

$39

Add

10 mg

$59

Add

25 mg

$136

Add

50 mg

$231

Add

NVP-AEW541 (hydrochloride)

An IGF-1R inhibitor

CAS No. 2320261-63-8

Item No. 13641

Formulation: A crystalline solid

Purity: ≥98%

500 µg

$90

Add

1 mg

$129

Add

5 mg

$481

Add

10 mg

$842

Add

SU 5402

An inhibitor of VEGFR2, FGFR1, and PDGFRβ

CAS No. 215543-92-3

Item No. 13182

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$31

Add

5 mg

$77

Add

10 mg

$139

Add

25 mg

$270

Add

Lenvatinib

An inhibitor of VEGFR2 and VEGFR3

CAS No. 417716-92-8

Item No. 19375

Formulation: A crystalline solid

Purity: ≥98%

E-7080
ER-203492-00

1 mg

$36

Add

5 mg

$95

Add

10 mg

$169

Add

25 mg

$378

Add

Sunitinib (malate)

A multi-kinase inhibitor

CAS No. 341031-54-7

Item No. 13159

Formulation: A crystalline solid

Purity: ≥98%

SU11248

1 mg

$33

Add

5 mg

$66

Add

10 mg

$116

Add

50 mg

$246

Add

Axitinib

A VEGFR inhibitor

CAS No. 319460-85-0

Item No. 13813

Formulation: A crystalline solid

Purity: ≥98%

AG-013736

50 mg

$85

Add

100 mg

$159

Add

500 mg

$663

Add

PKC 412

Kinase inhibitor with potential use in cancer treatment

CAS No. 120685-11-2

Item No. 10459

Formulation: A crystalline solid

Purity: ≥98%

N-Benzoylstaurosporine
CGP 41231
CGP 41251
Midostaurin

1 mg

$31

Add

5 mg

$93

Add

10 mg

$154

Add

25 mg

$270

Add

Axitinib-¹³C-d₃

An internal standard for the quantification of axitinib

CAS No. 1261432-00-1

Item No. 26676

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

AG-013736-¹³C-d₃

500 µg

$659

Add

1 mg

$1,054

Add

BIBF 1120-¹³C-d₃

An internal standard for the quantification of BIBF 1120

Item No. 25312

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

Nintedanib-¹³C-d₃

500 µg

$436

Add

1 mg

$827

Add

Regorafenib

A multi-kinase inhibitor

CAS No. 755037-03-7

Item No. 18498

Formulation: A crystalline solid

Purity: ≥98%

BAY 73-4506

5 mg

$49

Add

10 mg

$93

Add

25 mg

$130

Add

50 mg

$236

Add

Ponatinib

An inhibitor of native and mutant Bcr-Abl

CAS No. 943319-70-8

Item No. 11494

Formulation: A crystalline solid

Purity: ≥98%

AP 24534

1 mg

$32

Add

5 mg

$86

Add

10 mg

$109

Add

XL184

A VEGFR2 inhibitor

CAS No. 849217-68-1

Item No. 18464

Formulation: A crystalline solid

Purity: ≥98%

BMS-907351
Cabozantinib

1 mg

$49

Add

5 mg

$107

Add

10 mg

$167

Add

50 mg

$587

Add

BX-795

A multi-kinase inhibitor

CAS No. 702675-74-9

Item No. 14932

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$90

Add

10 mg

$168

Add

25 mg

$349

Add

50 mg

$653

Add

Pazopanib

A multi-kinase inhibitor

CAS No. 444731-52-6

Item No. 12097

Formulation: A crystalline solid

Purity: ≥98%

GSK-VEG10003
GW786034B

10 mg

$32

Add

25 mg

$72

Add

50 mg

$104

Add

100 mg

$160

Add

MAZ51

An antagonist of VEGFR3 (FLT4)

CAS No. 163655-37-6

Item No. 16168

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$54

Add

5 mg

$132

Add

10 mg

$209

Add

25 mg

$458

Add

Vandetanib

A multi-kinase inhibitor

CAS No. 443913-73-3

Item No. 14706

Formulation: A crystalline solid

Purity: ≥98%

CH 331
Zactima
ZD 6474

5 mg

$41

Add

10 mg

$72

Add

25 mg

$119

Add

100 mg

$341

Add

Pazopanib-d₆

An internal standard for the quantification of pazopanib

CAS No. 1219592-01-4

Item No. 25446

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₆)

500 µg

$319

Add

1 mg

$604

Add

Apatinib

A selective VEGFR2 inhibitor

CAS No. 811803-05-1

Item No. 21268

Formulation: A crystalline solid

Purity: ≥98%

YN968D1

5 mg

$103

Add

10 mg

$194

Add

25 mg

$502

Add

50 mg

$801

Add

AZD 4547

A selective inhibitor of FGFR tyrosine kinases

CAS No. 1035270-39-3

Item No. 13111

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$121

Add

10 mg

$182

Add

50 mg

$655

Add

Neratinib

A dual inhibitor of EGFR and HER2

CAS No. 698387-09-6

Item No. 18404

Formulation: A crystalline solid

Purity: ≥98%

HKI-272

10 mg

$42

Add

25 mg

$63

Add

50 mg

$95

Add

100 mg

$147

Add

N-desethyl Sunitinib

An active metabolite of sunitinib

CAS No. 356068-97-8

Item No. 22292

Formulation: A crystalline solid

Purity: ≥95%

SU 12662

500 µg

$41

Add

1 mg

$75

Add

5 mg

$312

Add

10 mg

$467

Add

Dovitinib

A multi-kinase inhibitor

CAS No. 405169-16-6

Item No. 15220

Formulation: A crystalline solid

Purity: ≥98%

CHIR258
TKI-258

5 mg

$134

Add

10 mg

$213

Add

25 mg

$345

Add

50 mg

$556

Add

Displaying 1 - 25 of 124 Results

Cart Subtotal:$0

New Products

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d6)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Purity: ≥99% deuterated forms (d₁-d₃)

Purity: ≥99% deuterated forms (d₁-d₃)

Purity: ≥99% deuterated forms (d₁-d₆)